Mesa Laboratories Enhances Financial Structure and Reduces Debt
Company Announcements

Mesa Laboratories Enhances Financial Structure and Reduces Debt

Mesa Laboratories (MLAB) just unveiled an update.

Mesa Laboratories, Inc. recently revised its senior secured credit agreement with a banking syndicate led by JPMorgan Chase, enhancing its financial flexibility. The modifications include a new $75 million term loan, an extended credit facility maturity to April 2029, and adjustments to financial covenants. The company also retains a $125 million revolving credit facility to support its working capital and corporate needs, including potential acquisitions. Additionally, Mesa has negotiated the repurchase of $75 million of its 1.375% Convertible Notes due in 2025, reducing its outstanding debt and streamlining its capital structure.

For a thorough assessment of MLAB stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyMesa Labs price target lowered to $150 from $160 at Evercore ISI
TipRanks Auto-Generated NewsdeskMesa Laboratories Reports Robust Q2 FY25 Results
TheFlyMesa Labs reports Q2 EPS 63c vs (23c) last year
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App